Fideres is pleased to announce that, following the publication by The Guardian of its research into excessively priced Covid-19 travel tests, several organisations including the UK government have launched investigations. On 31st July, a…
Read More
Fideres responds to the Competition and Markets Authority’s consultation on its annual plan for 2020/21 The CMA’s annual plan makes important strides into the future, but falls short in the…
Read our article, ‘Relaxing UK Competition Laws is a Mistake’, on Legal Week. Fideresfideres.com
PRESS RELEASE FIDERES’S PROPOSAL FOR A TWO STAGE PLAN TO FIX CBILS Fideresfideres.com
Fideres’ analysis of the global nature of public sector bond mispricing was highlighted in a recent report by Practice Insights. Founding partner Alberto Thomas provided comments on the shortcomings of…
Fideres’ research on possible municipal bond mispricing was covered today by Bloomberg. The research analysed the pricing of municipal bonds (Muni Bonds) and found that underwriters systematically misprice them. The…
The Philadelphia Inquirer recently covered Fideres’ recent research on price increases of generic drugs as part of a full examination of the pharmaceutical industry. Alberto Thomas, founding parter at Fideres,…
Fideres’ research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases….
Labaton and Hausfeld have filed a class action in the U.S. alleging a conspiracy in the Supranational, Sub-sovereign and Agency bonds (SSA) market. Fideres’ analysis has been included in the…
Fideres research has been reported on by Bloomberg, Reuters and a number of other news organisations. The research found evidence of systemic under-pricing in the bond market, potentially costing bond…
